These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34278191)

  • 1. Low-dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors.
    Li Z; Chen Z; Liu G; Cheng X; Yao W; Huang K; Li G; Zhen Y; Wu X; Cai S; Poon MC; Wu R
    Res Pract Thromb Haemost; 2021 Jul; 5(5):e12562. PubMed ID: 34278191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose immune tolerance induction for children with hemophilia A with poor-risk high-titer inhibitors: A pilot study in China.
    Li Z; Chen Z; Cheng X; Wu X; Li G; Zhen Y; Cai S; Poon MC; Wu R
    Res Pract Thromb Haemost; 2019 Oct; 3(4):741-748. PubMed ID: 31624794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor-titer below 200 BU/mL.
    Li Z; Sun J; Li Z; Chen Z; Liu G; Yao W; Cheng X; Li G; Zhen Y; Ai D; Zhou Y; Mao Q; Poon MC; Wu R
    Pediatr Investig; 2024 Jun; 8(2):91-100. PubMed ID: 38910855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose immune tolerance induction therapy in children of Arab descent with severe haemophilia A, high inhibitor titres and poor prognostic factors for immune tolerance induction treatment success.
    Elalfy M; Elghamry I; Hassab H; Elalfy O; Andrawes N; El-Ekiaby M
    Haemophilia; 2022 Jan; 28(1):65-72. PubMed ID: 34797008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
    Kreuz W; Escuriola Ettingshausen C; Vdovin V; Zozulya N; Plyushch O; Svirin P; Andreeva T; Bubanská E; Campos M; Benedik-Dolničar M; Jiménez-Yuste V; Kitanovski L; Klukowska A; Momot A; Osmulskaya N; Prieto M; Šalek SZ; Velasco F; Pavlova A; Oldenburg J; Knaub S; Jansen M; Belyanskaya L; Walter O; ;
    Haemophilia; 2016 Jan; 22(1):87-95. PubMed ID: 26202305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
    Gringeri A; Musso R; Mazzucconi MG; Piseddu G; Schiavoni M; Pignoloni P; Mannucci PM;
    Haemophilia; 2007 Jul; 13(4):373-9. PubMed ID: 17610550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study.
    Escuriola Ettingshausen C; Vdovin V; Zozulya N; Svirin P; Andreeva T; Benedik-Dolničar M; Jiménez-Yuste V; Kitanovski L; Zupancic-Šalek S; Pavlova A; Bátorová A; Montaño Mejía C; Abdilova G; Knaub S; Jansen M; Lowndes S; Belyanskaya L; Walter O; Oldenburg J;
    TH Open; 2022 Apr; 6(2):e124-e134. PubMed ID: 35707623
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune tolerance induction in patients with severe hemophilia A with inhibitors.
    Ryu JE; Park YS; Yoo KY; Lee KD; Choi YM
    Blood Res; 2015 Dec; 50(4):248-53. PubMed ID: 26770953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
    Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
    Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysis.
    Oomen I; Camelo RM; Rezende SM; Voorberg J; Mancuso ME; Oldenburg J; Carcao M; Matino D; Lillicrap D; Fischer K; Fijnvandraat K; Gouw SC;
    Res Pract Thromb Haemost; 2023 Jan; 7(1):100020. PubMed ID: 36891524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes.
    Li Z; Sun J; Li Z; Chen Z; Liu G; Yao W; Li G; Zhen Y; Cheng X; Ai D; Huang K; Poon MC; Wu R
    Thromb Res; 2023 May; 225():33-38. PubMed ID: 36934482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful immune tolerance induction with low-dose coagulation factor VIII in a patient with hemophilia A from a developing country.
    Ay Y; Ersin T; Yesim O; Hilkay KT; Dilek I; Gulcihan O; Ahmet K
    Blood Coagul Fibrinolysis; 2016 Sep; 27(6):729-31. PubMed ID: 26484639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors.
    Unuvar A; Warrier I; Lusher JM
    Haemophilia; 2000 May; 6(3):150-7. PubMed ID: 10792472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low-dose regimens.
    Lin PC; Liao YM; Tsai SP; Chang TT
    Pediatr Blood Cancer; 2011 Dec; 57(6):1029-33. PubMed ID: 21793191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.
    Ter Avest PC; Fischer K; Gouw SC; Van Dijk K; Mauser-Bunschoten EP
    Haemophilia; 2010 May; 16(102):71-9. PubMed ID: 20536988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune tolerance induction (ITI) dose debate: does the International ITI Study provide a clearer picture?
    Ettingshausen CE; Kreuz W
    Haemophilia; 2013 Jan; 19 Suppl 1():12-7. PubMed ID: 23278995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of bleeding before and during immune tolerance in 222 boys with severe hemophilia A and inhibitors >5 BU.
    Fischer K; Kenet G; Kurnik K; Carcao M; Oldenburg J; Stamm-Mikkelsen T; Cid Haro AR; Koskenvuo M; Blatny J; Königs C
    Blood Adv; 2024 Jan; 8(2):369-377. PubMed ID: 38214949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors.
    Coppola A; Margaglione M; Santagostino E; Rocino A; Grandone E; Mannucci PM; Di Minno G;
    J Thromb Haemost; 2009 Nov; 7(11):1809-15. PubMed ID: 19740093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term course of anti-factor VIII antibody in patients with hemophilia A at a single center.
    Yoo KY; Joo SC; Choi YM
    Blood Res; 2016 Mar; 51(1):37-43. PubMed ID: 27104190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.